Role of matrix metalloproteinases in the invasion of glioblastoma and drug interventions (Review)

Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020. Neuro Oncol. 25(12 Suppl 2): iv1–iv99. 2023. View Article : Google Scholar : PubMed/NCBI

Xiao D, Yan C, Li D, Xi T, Liu X, Zhu D, Huang G, Xu J, He Z, Wu A, et al: National brain tumour registry of China (NBTRC) statistical report of primary brain tumours diagnosed in china in years 2019-2020. Lancet Reg Health West Pac. 34:1007152023.PubMed/NCBI

Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, et al: The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro Oncol. 23:1231–1251. 2021. View Article : Google Scholar : PubMed/NCBI

Barone DG, Lawrie TA and Hart MG: Image guided surgery for the resection of brain tumours. Cochrane Database Syst Rev. 2014:CD0096852014.PubMed/NCBI

Pirro V, Alfaro CM, Jarmusch AK, Hattab EM, Cohen-Gadol AA and Cooks RG: Intraoperative assessment of tumor margins during glioma resection by desorption electrospray ionization-mass spectrometry. Proc Natl Acad Sci USA. 114:6700–6705. 2017. View Article : Google Scholar : PubMed/NCBI

De Boer E, Harlaar NJ, Taruttis A, Nagengast WB, Rosenthal EL, Ntziachristos V and Van Dam GM: Optical innovations in surgery. Br J Surg. 102:e56–e72. 2015. View Article : Google Scholar : PubMed/NCBI

Hervey-Jumper SL and Berger MS: Maximizing safe resection of low- and high-grade glioma. J Neuro-Oncol. 130:269–282. 2016. View Article : Google Scholar

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI

Perry JR, Laperriere N, O'Callaghan CJ, Brandes AA, Menten J, Phillips C, Fay M, Nishikawa R, Cairncross JG, Roa W, et al: Short-course radiation plus temozolomide in elderly patients with glioblastoma. N Engl J Med. 376:1027–1037. 2017. View Article : Google Scholar : PubMed/NCBI

Rodríguez-Camacho A, Flores-Vázquez JG, Moscardini-Martelli J, Torres-Ríos JA, Olmos-Guzmán A, Ortiz-Arce CS, Cid-Sánchez DR, Pérez SR, Macías-González MDS, Hernández-Sánchez LC, et al: Glioblastoma treatment: State-of-the-art and future perspectives. Int J Mol Sci. 23:72072022. View Article : Google Scholar : PubMed/NCBI

Weller M and Le Rhun E: How did lomustine become standard of care in recurrent glioblastoma? Cancer Treat Rev. 87:1020292020. View Article : Google Scholar : PubMed/NCBI

Kirson ED, Dbalý V, Tovaryš F, Vymazal J, Soustiel JF, Itzhaki A, Mordechovich D, Steinberg-Shapira S, Gurvich Z, Schneiderman R, et al: Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. Proc Natl Acad Sci USA. 104:10152–10157. 2007. View Article : Google Scholar : PubMed/NCBI

Giladi M, Schneiderman RS, Voloshin T, Porat Y, Munster M, Blat R, Sherbo S, Bomzon Z, Urman N, Itzhaki A, et al: Mitotic spindle disruption by alternating electric fields leads to improper chromosome segregation and mitotic catastrophe in cancer cells. Sci Rep. 5:180462015. View Article : Google Scholar : PubMed/NCBI

Stupp R, Taillibert S, Kanner A, Read W, Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, et al: Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: A randomized clinical trial. JAMA. 318:2306–2316. 2017. View Article : Google Scholar : PubMed/NCBI

Chinot OL, Wick W, Mason W, Henriksson R, Saran F, Nishikawa R, Carpentier AF, Hoang-Xuan K, Kavan P, Cernea D, et al: Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med. 370:709–722. 2014. View Article : Google Scholar : PubMed/NCBI

Le Rhun E, Preusser M, Roth P, Reardon DA, van den Bent M, Wen P, Reifenberger G and Weller M: Molecular targeted therapy of glioblastoma. Cancer Treat Rev. 80:1018962019. View Article : Google Scholar : PubMed/NCBI

Navone SE, Guarnaccia L, Locatelli M, Rampini P, Caroli M, La Verde N, Gaudino C, Bettinardi N, Riboni L, Marfia G and Campanella R: Significance and prognostic value of the coagulation profile in patients with glioblastoma: Implications for personalized therapy. World Neurosurg. 121:e621–e629. 2019. View Article : Google Scholar

Cuddapah VA, Robel S, Watkins S and Sontheimer H: A neurocentric perspective on glioma invasion. Nat Rev Neurosci. 15:455–465. 2014. View Article : Google Scholar : PubMed/NCBI

Streiff MB, Ye X, Kickler TS, Desideri S, Jani J, Fisher J and Grossman SA: A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: Hazard rate and risk factors. J Neurooncol. 124:299–305. 2015. View Article : Google Scholar : PubMed/NCBI

Chen Y, Fei W, Shi Y, Ma W, Jiao W, Tao F, Zhu J, Wang Y and Feng X: Venous thromboembolism risk factors in pediatric patients with high-grade glioma: A multicenter retrospective study. Front Pediatr. 13:15952232025. View Article : Google Scholar : PubMed/NCBI

Marras LC, Geerts WH and Perry JR: The risk of venous thromboembolism is increased throughout the course of malignant glioma: An evidence-based review. Cancer. 89:640–646. 2000. View Article : Google Scholar : PubMed/NCBI

Semrad TJ, O'Donnell R, Wun T, Chew H, Harvey D, Zhou H and White RH: Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg. 106:601–608. 2007. View Article : Google Scholar : PubMed/NCBI

Brat DJ, Castellano-Sanchez AA, Hunter SB, Pecot M, Cohen C, Hammond EH, Devi SN, Kaur B and Van Meir EG: Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res. 64:920–927. 2004. View Article : Google Scholar : PubMed/NCBI

Gross J and Lapiere CM: Collagenolytic activity in amphibian tissues: A tissue culture assay. Proc Natl Acad Sci USA. 48:1014–1022. 1962. View Article : Google Scholar : PubMed/NCBI

Visse R and Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res. 92:827–839. 2003. View Article : Google Scholar : PubMed/NCBI

Quintero-Fabián S, Arreola R, Becerril-Villanueva E, Torres-Romero JC, Arana-Argáez V, Lara-Riegos J, Ramírez-Camacho MA and Alvarez-Sánchez ME: Role of matrix metalloproteinases in angiogenesis and cancer. Front Oncol. 9:13702019. View Article : Google Scholar

Gialeli C, Theocharis AD and Karamanos NK: Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 278:16–27. 2011. View Article : Google Scholar

Niland S, Riscanevo AX and Eble JA: Matrix metalloproteinases shape the tumor microenvironment in cancer progression. Int J Mol Sci. 23:1462021. View Article : Google Scholar

Dibdiakova K, Majercikova Z, Galanda T, Richterova R, Kolarovszki B, Racay P and Hatok J: Relationship between the expression of matrix metalloproteinases and their tissue inhibitors in patients with brain tumors. Int J Mol Sci. 25:28582024. View Article : Google Scholar : PubMed/NCBI

Wolburg H, Noell S, Fallier-Becker P, Mack AF and Wolburg-Buchholz K: The disturbed blood-brain barrier in human glioblastoma. Mol Aspects Med. 33:579–589. 2012. View Article : Google Scholar : PubMed/NCBI

Zhang S, Cheng L, Su Y, Qian Z, Wang Z, Chen C, Li R, Zhang A, He J, Mao J, et al: AGBL4 promotes malignant progression of glioblastoma via modulation of MMP-1 and inflammatory pathways. Front Immunol. 15:14201822024. View Article : Google Scholar : PubMed/NCBI

Huang ZL, Abdallah AS, Shen GX, Suarez M, Feng P, Yu YJ, Wang Y, Zheng SH, Hu YJ, Xiao X, et al: Silencing GMPPB inhibits the proliferation and invasion of GBM via hippo/MMP3 pathways. Int J Mol Sci. 24:147072023. View Article : Google Scholar : PubMed/NCBI

Yan P, Wang J, Liu H, Liu X, Fu R and Feng J: M1 macrophage-derived exosomes containing miR-150 inhibit glioma progression by targeting MMP16. Cell Signal. 108:1107312023. View Article : Google Scholar : PubMed/NCBI

Hitchcock SA: Blood-brain barrier permeability considerations for CNS-targeted compound library design. Curr Opin Chem Biol. 12:318–323. 2008. View Article : Google Scholar : PubMed/NCBI

Xie HJ, Zhan-Dui N, Zhao J, Er-Bu AGA, Zhen P, ZhuoMa D and Sang T: Evaluation of nanoscaled dual targeting drug-loaded liposomes on inhibiting vasculogenic mimicry channels of brain glioma. Artif Cells Nanomed Biotechnol. 49:595–604. 2021. View Article : Google Scholar

Tian S, Xu J, Qiao X, Zhang X, Zhang S, Zhang Y, Xu C, Wang H and Fang C: CuO nanoparticles for glioma treatment in vitro and in vivo. Sci Rep. 14:232292024. View Article : Google Scholar : PubMed/NCBI

Castro-Ribeiro ML, Castro VIB, Vieira De Castro J, Pires RA, Reis RL, Costa BM, Ferreira H and Neves NM: The potential of the fibronectin inhibitor arg-gly-asp-ser in the development of therapies for glioblastoma. Int J Mol Sci. 25:49102024. View Article : Google Scholar : PubMed/NCBI

Yang WB, Chuang JY, Ko CY, Chang WC and Hsu TI: Dehydroepiandrosterone induces temozolomide resistance through modulating phosphorylation and acetylation of Sp1 in glioblastoma. Mol Neurobiol. 56:2301–2313. 2019. View Article : Google Scholar

Munoz JL, Bliss SA, Greco SJ, Ramkissoon SH, Ligon KL and Rameshwar P: Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity. Mol Ther Nucleic Acids. 2:e1262013. View Article : Google Scholar : PubMed/NCBI

McFaline-Figueroa JL, Braun CJ, Stanciu M, Nagel ZD, Mazzucato P, Sangaraju D, Cerniauskas E, Barford K, Vargas A, Chen Y, et al: Minor changes in expression of the mismatch repair protein MSH2 exert a major impact on glioblastoma response to temozolomide. Cancer Res. 75:3127–3138. 2015. View Article : Google Scholar : PubMed/NCBI

Song H and Park KH: Regulation and function of SOX9 during cartilage development and regeneration. Semin Cancer Biol. 67(Pt 1): 12–23. 2020. View Article : Google Scholar : PubMed/NCBI

Guo XR, Wu MY, Dai LJ, Huang Y, Shan MY, Ma SN, Wang J, Peng H, Ding Y, Zhang QF, et al: Nuclear FAM289-galectin-1 interaction controls FAM289-mediated tumor promotion in malignant glioma. J Exp Clin Cancer Res. 38:3942019. View Article : Google Scholar : PubMed/NCBI

Yan H, Fu Z, Lin P, Gu Y, Cao J and Li Y: Inhibition of human glioblastoma multiforme cells by 10,11-dehydrocurvularin through the MMP-2 and PI3K/AKT signaling pathways. Eur J Pharmacol. 936:1753482022. View Article : Google Scholar : PubMed/NCBI

Yuan Z, Yang Z, Li W, Wu A, Su Z, Jiang B and Ganesan S: Triphlorethol-a attenuates U251 human glioma cancer cell proliferation and ameliorates apoptosis through JAK2/STAT3 and p38 MAPK/ERK signaling pathways. J Biochem Mol Toxicol. 36:e231382022. View Article : Google Scholar

De Jong JM, Broekaart DWM, Bongaarts A, Mühlebner A, Mills JD, Van Vliet EA and Aronica E: Altered extracellular matrix as an alternative risk factor for epileptogenicity in brain tumors. Biomedicines. 10:24752022. View Article : Google Scholar : PubMed/NCBI

Thome I, Lacle R, Voß A, Bortolussi G, Pantazis G, Schmidt A, Conrad C, Jacob R, Timmesfeld N, Bartsch JW and Pagenstecher A: Neoplastic cells are the major source of MT-MMPs in IDH1-mutant glioma, thus enhancing tumor-cell intrinsic brain infiltration. Cancers (Basel). 12:24562020. View Article : Google Scholar : PubMed/NCBI

Sawicka MM, Sawicki K, Jadeszko M, Bielawska K, Supruniuk E, Reszeć J, Prokop-Bielenia I, Polityńska B, Jadeszko M, Rybaczek M, et al: Proline metabolism in WHO G4 gliomas is altered as compared to unaffected brain tissue. Cancers (Basel). 16:4562024. View Article : Google Scholar : PubMed/NCBI

Whitehead CA, Fang H, Su H, Morokoff AP, Kaye AH, Hanssen E, Nowell CJ, Drummond KJ, Greening DW, Vella LJ, et al: Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner. Cell Oncol (Dordr). 46:909–931. 2023. View Article : Google Scholar : PubMed/NCBI

Colangelo NW and Azzam EI: Extracellular vesicles originating from glioblastoma cells increase metalloproteinase release by astrocytes: The role of CD147 (EMMPRIN) and ionizing radiation. Cell Commun Signaling. 18:212020. View Article : Google Scholar

Perruzzi CA, De Fougerolles AR, Koteliansky VE, Whelan MC, Westlin WF and Senger DR: Functional overlap and cooperativity among αv and β1 integrin subfamilies during skin angiogenesis. J Invest Dermatol. 120:1100–1109. 2003. View Article : Google Scholar : PubMed/NCBI

Whelan MC and Senger DR: Collagen I initiates endothelial cell morphogenesis by inducing actin polymerization through suppression of cyclic AMP and protein kinase A. J Biol Chem. 278:327–334. 2003. View Article : Google Scholar

Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC and Yancopoulos GD: Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 87:1161–1169. 1996. View Article : Google Scholar : PubMed/NCBI

Winer A, Adams S and Mignatti P: Matrix metalloproteinase inhibitors in cancer therapy: Turning past failures into future successes. Mol Cancer Ther. 17:1147–1155. 2018. View Article : Google Scholar : PubMed/NCBI

Jiguet-Jiglaire C, Boissonneau S, Denicolai E, Hein V, Lasseur R, Garcia J, Romain S, Appay R, Graillon T, Mason W, et al: Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: An AVAglio ancillary study. Acta Neuropathol Commun. 10:12022. View Article : Google Scholar : PubMed/NCBI

Luo W, Quan Q, Xu Z, Lei J and Peng R: Bioinformatics analysis of MMP14+ myeloid cells affecting endothelial-mesenchymal transformation and immune microenvironment in glioma. Heliyon. 10:e268592024. View Article : Google Scholar : PubMed/NCBI

Yi B, Li H, Cai H, Lou X, Yu M and Li Z: LOXL1-AS1 communicating with TIAR modulates vasculogenic mimicry in glioma via regulation of the miR-374b-5p/MMP14 axis. J Cell Mol Med. 26:475–490. 2022. View Article : Google Scholar

Kryczka J, Papiewska-Pajak I, Kowalska MA and Boncela J: Cathepsin B is upregulated and mediates ECM degradation in colon adenocarcinoma HT29 cells overexpressing snail. Cells. 8:2032019. View Article : Google Scholar : PubMed/NCBI

Adnani L, Kassouf J, Meehan B, Spinelli C, Tawil N, Nakano I and Rak J: Angiocrine extracellular vesicles impose mesenchymal reprogramming upon proneural glioma stem cells. Nat Commun. 13:54942022. View Article : Google Scholar : PubMed/NCBI

Djediai S, Gonzalez Suarez N, El Cheikh-Hussein L, Rodriguez Torres S, Gresseau L, Dhayne S, Joly-Lopez Z and Annabi B: MT1-MMP cooperates with TGF-β receptor-mediated signaling to trigger SNAIL and induce epithelial-to-mesenchymal-like transition in U87 glioblastoma cells. Int J Mol Sci. 22:130062021. View Article : Google Scholar

Komatsu K, Nakanishi Y, Nemoto N, Hori T, Sawada T and Kobayashi M: Expression and quantitative analysis of matrix metalloproteinase-2 and-9 in human gliomas. Brain Tumor Pathol. 21:105–112. 2004. View Article : Google Scholar

Hormigo A, Gu B, Karimi S, Riedel E, Panageas KS, Edgar MA, Tanwar MK, Rao JS, Fleisher M, DeAngelis LM and Holland EC: YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas. Clin Cancer Res. 12:5698–5704. 2006. View Article : Google Scholar : PubMed/NCBI

Iwamoto FM, Hottinger AF, Karimi S, Riedel E, Dantis J, Jahdi M, Panageas KS, Lassman AB, Abrey LE, Fleisher M, et al: Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas. J Neuro-oncol. 105:607–612. 2011. View Article : Google Scholar

Wong ET, Alsop D, Lee D, Tam A, Barron L, Bloom J, Gautam S and Wu JK: Cerebrospinal fluid matrix metalloproteinase-9 increases during treatment of recurrent malignant gliomas. Cerebrospinal Fluid Res. 5:12008. View Article : Google Scholar : PubMed/NCBI

Tabouret E, Boudouresque F, Barrie M, Matta M, Boucard C, Loundou A, Carpentier A, Sanson M, Metellus P, Figarella-Branger D, et al: Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma. Neuro Oncol. 16:392–399. 2014. View Article : Google Scholar :

Li Q, Chen B, Cai J, Sun Y, Wang G, Li Y, Li R, Feng Y, Han B, Li J, et al: Comparative analysis of matrix metalloproteinase family members reveals that MMP9 predicts survival and response to temozolomide in patients with primary glioblastoma. PLoS One. 11:e01518152016. View Article : Google Scholar : PubMed/NCBI

Zhang J, Yang Y, Dong Y and Liu C: Microrchidia family CW-type zinc finger 2 promotes the proliferation, invasion, migration and epithelial-mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N-myc downstream regulated gene 1 promoter. Int J Mol Med. 49:162022. View Article : Google Scholar :

Liu Y, Ma J, Song JS, Zhou HY, Li JH, Luo C, Geng X and Zhao HX: DNA topoisomerase II alpha promotes the metastatic characteristics of glioma cells by transcriptionally activating β-catenin. Bioengineered. 13:2207–2216. 2022. View Article : Google Scholar : PubMed/NCBI

Cong Z, Yuan F, Wang H, Cai X, Zhu J, Tang T, Zhang L, Han Y and Ma C: BTB domain and CNC homolog 1 promotes glioma invasion mainly through regulating extracellular matrix and increases ferroptosis sensitivity. Biochim Biophys Acta Mol Basis Dis. 1868:1665542022. View Article : Google Scholar : PubMed/NCBI

Pai FC, Huang HW, Tsai YL, Tsai WC, Cheng YC, Chang HH and Chen Y: Inhibition of FABP6 reduces tumor cell invasion and angiogenesis through the decrease in MMP-2 and VEGF in human glioblastoma cells. Cells. 10:27822021. View Article : Google Scholar : PubMed/NCBI

Hu T, Lei D, Zhou J and Zhang B: circRNA derived from CLSPN (circCLSPN) is an oncogene in human glioblastoma multiforme by regulating cell growth, migration and invasion via ceRNA pathway. J Biosci. 46:662021. View Article : Google Scholar : PubMed/NCBI

Jia J, Ouyang Z, Wang M, Ma W, Liu M, Zhang M and Yu M: MicroRNA-361-5p slows down gliomas development through regulating UBR5 to elevate ATMIN protein expression. Cell Death Dis. 12:7462021. View Article : Google Scholar : PubMed/NCBI

Amini J, Zafarjafarzadeh N, Ghahramanlu S, Mohammadalizadeh O, Mozaffari E, Bibak B and Sanadgol N: Role of circular RNA MMP9 in glioblastoma progression: from interaction with hnRNPC and hnRNPA1 to affecting the expression of BIRC5 by sequestering miR -149. J Mol Recognit. 38:e31092025. View Article : Google Scholar

Delbrouck C, Kiweler N, Chen O, Pozdeev VI, Haase L, Neises L, Oudin A, Fouquier d'Hérouël A, Shen R, Schlicker L, et al: Formate promotes invasion and metastasis in reliance on lipid metabolism. Cell Rep. 42:1130342023. View Article : Google Scholar : PubMed/NCBI

Pu W, Qiu J, Riggins GJ and Parat MO: Matrix protease production, epithelial-to-mesenchymal transition marker expression and invasion of glioblastoma cells in response to osmotic or hydrostatic pressure. Sci Rep. 10:26342020. View Article : Google Scholar : PubMed/NCBI

Liu Y, He W, Guo Y, Qu S, Yao F, Liu J, Chai J, Yang Y, Xu T, Liu Y, et al: CSNK1D is associated with stemness and invasiveness in glioblastoma. Pathol Res Pract. 240:1541872022. View Article : Google Scholar : PubMed/NCBI

Vivanco I and Sawyers CL: The phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nat Rev Cancer. 2:489–501. 2002. View Article : Google Scholar : PubMed/NCBI

Huang YK, Wang TM, Chen CY, Li CY, Wang SC, Irshad K, Pan Y and Chang KC: The role of ALDH1A1 in glioblastoma proliferation and invasion. Chem Biol Interact. 402:1112022024. View Article : Google Scholar : PubMed/NCBI

Ni H, Ji D, Huang Z and Li J: SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/akt pathway. Arch Biochem Biophys. 695:1086282020. View Article : Google Scholar : PubMed/NCBI

Yang W, Yuan Q, Zhang S, Zuo M, Li T, Li J, Zhou X, Li M, Feng W, Xia X, et al: Elevated GIGYF2 expression suppresses tumor migration and enhances sensitivity to temozolomide in malignant glioma. Cancer Gene Ther. 29:750–757. 2022. View Article : Google Scholar

Gwon DH, Lee WY, Shin N, Kim SI, Jeong K, Lee WH, Kim DW, Hong J and Lee SY: BMAL1 suppresses proliferation, migration, and invasion of U87MG cells by downregulating cyclin B1, phospho-AKT, and metalloproteinase-9. Int J Mol Sci. 21:23522020. View Article : Google Scholar : PubMed/NCBI

Zuo J, Liu C, Ni H and Yu Z: WDR34 affects PI3K/akt and wnt/β-catenin pathways to regulates malignant biological behaviors of glioma cells. J Neurooncol. 156:281–293. 2022. View Article : Google Scholar : PubMed/NCBI

Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R, et al: Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell. 9:287–300. 2006. View Article : Google Scholar : PubMed/NCBI

Lyu X, Shi Y, Wang D, Cao X, Guo J, Huang G, Zhou L, Zhang M and Dong Z: Impact of LIN7A silencing on U87 cell invasion and its clinical significance in glioblastoma. Sci Rep. 15:72122025. View Article : Google Scholar : PubMed/NCBI

Sun H, Long S, Wu B, Liu J and Li G: NKCC1 involvement in the epithelial-to-mesenchymal transition is a prognostic biomarker in gliomas. PeerJ. 8:e87872020. View Article : Google Scholar : PubMed/NCBI

Zhang G, Feng W and Wu J: Down-regulation of SEPT9 inhibits glioma progression through suppressing TGF-β-induced epithelial-mesenchymal transition (EMT). Biomed Pharmacother. 125:1097682020. View Article : Google Scholar

Dong C, Li X, Yang J, Yuan D, Zhou Y, Zhang Y, Shi G, Zhang R, Liu J, Fu P and Sun M: PPFIBP1 induces glioma cell migration and invasion through FAK/src/JNK signaling pathway. Cell Death Dis. 12:8272021. View Article : Google Scholar : PubMed/NCBI

Zhang Y, Chang L, Huang P, Cao M, Hong R, Zhao X, He X and Xu L: Loss of PTPRS elicits potent metastatic capability and resistance to temozolomide in glioblastoma. Mol Carcinog. 63:1235–1247. 2024. View Article : Google Scholar : PubMed/NCBI

Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, et al: Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 9:157–173. 2006. View Article : Google Scholar : PubMed/NCBI

Costa BM, Smith JS, Chen Y, Chen J, Phillips HS, Aldape KD, Zardo G, Nigro J, James CD, Fridlyand J, et al: Reversing HOXA9 oncogene activation by PI3K inhibition: Epigenetic mechanism and prognostic significance in human glioblastoma. Cancer Res. 70:453–462. 2010. View Article : Google Scholar : PubMed/NCBI

Lin K, Taylor JR Jr, Wu TD, Gutierrez J, Elliott JM, Vernes JM, Koeppen H, Phillips HS, de Sauvage FJ and Meng YG: TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including glioma. PLoS One. 6:e186082011. View Article : Google Scholar : PubMed/NCBI

Yu X, Jin J, Zheng Y, Zhu H, Xu H, Ma J, Lan Q, Zhuang Z, Chen CC and Li M: GBP5 drives malignancy of glioblastoma via the src/ERK1/2/MMP3 pathway. Cell Death Dis. 12:2032021. View Article : Google Scholar : PubMed/NCBI

Wang R, Zhang S, Chen X, Li N, Li J, Jia R, Pan Y and Liang H: EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis. Mol Cancer. 17:1662018. View Article : Google Scholar : PubMed/NCBI

Liu X, Shen S, Zhu L, Su R, Zheng J, Ruan X, Shao L, Wang D, Yang C and Liu Y: SRSF10 inhibits biogenesis of circ-ATXN1 to regulate glioma angiogenesis via miR-526b-3p/MMP2 pathway. J Exp Clin Cancer Res. 39:1212020. View Article : Google Scholar : PubMed/NCBI

Yang Y and Zhao F: MicroRNA-16 inhibits the growth and metastasis of human glioma cells via modulation of PI3K/AKT/mTOR signalling pathway. Arch Med Sci. 20:839–846. 2020. View Article : Google Scholar : PubMed/NCBI

Song Y, Li C, Jin L, Xing J, Sha Z, Zhang T, Ji D, Yu R and Gao S: RIOK2 is negatively regulated by miR-4744 and promotes glioma cell migration/invasion through epithelial-mesenchymal transition. J Cell Mol Med. 24:4494–4509. 2020. View Article : Google Scholar : PubMed/NCBI

Meiser J, Schuster A, Pietzke M, Vande Voorde J, Athineos D, Oizel K, Burgos-Barragan G, Wit N, Dhayade S, Morton JP, et al: Increased formate overflow is a hallmark of oxidative cancer. Nat Commun. 9:13682018. View Article : Google Scholar : PubMed/NCBI

Manou D, Golfinopoulou MA, Alharbi SND, Alghamdi HA, Alzahrani FM and Theocharis AD: The expression of serglycin is required for active transforming growth factor β receptor I tumorigenic signaling in glioblastoma cells and paracrine activation of stromal fibroblasts via CXCR-2. Biomolecules. 14:4612024. View Article : Google Scholar

Pu W, Qiu J, Nassar ZD, Shaw PN, McMahon KA, Ferguson C, Parton RG, Riggins GJ, Harris JM and Parat MO: A role for caveola-forming proteins caveolin-1 and CAVIN1 in the pro-invasive response of glioblastoma to osmotic and hydrostatic pressure. J Cell Mol Med. 24:3724–3738. 2020. View Article : Google Scholar : PubMed/NCBI

Pu W, Nassar ZD, Khabbazi S, Xie N, McMahon KA, Parton RG, Riggins GJ, Harris JM and Parat MO: Correlation of the invasive potential of glioblastoma and expression of caveola-forming proteins caveolin-1 and CAVIN1. J Neurooncol. 143:207–220. 2019. View Article : Google Scholar : PubMed/NCBI

Oishi M, Munesue S, Harashima A, Nakada M, Yamamoto Y and Hayashi Y: Aquaporin 1 elicits cell motility and coordinates vascular bed formation by downregulating thrombospondin type-1 domain-containing 7A in glioblastoma. Cancer Med. 9:3904–3917. 2020. View Article : Google Scholar : PubMed/NCBI

Sun Z, Zhao W, Fei X, He B, Shi L, Zhang Z and Cai S: Static magnetic field inhibits epithelial mesenchymal transition and metastasis of glioma. Sci Rep. 15:124302025. View Article : Google Scholar : PubMed/NCBI

Shi Y, Jiang J, Cui Y, Chen Y, Dong T, An H and Liu P: MSH6 aggravates the hypoxic microenvironment via regulating HIF1A to promote the metastasis of glioblastoma multiforme. DNA Cell Biol. 40:93–100. 2021. View Article : Google Scholar

Feng K, Ye G, Wang H, Li S, Wen X and Chen M: Research on the mechanism of TWSG1 in the malignant progression of glioma cells and tumor-associated macrophage infiltration. J Neuropathol Exp Neurol. 83:843–852. 2024. View Article : Google Scholar : PubMed/NCBI

Hodgson JG, Yeh RF, Ray A, Wang NJ, Smirnov I, Yu M, Hariono S, Silber J, Feiler HS, Gray JW, et al: Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts. Neuro Oncol. 11:477–487. 2009. View Article : Google Scholar : PubMed/NCBI

Korde LA, Lusa L, McShane L, Lebowitz PF, Lukes L, Camphausen K, Parker JS, Swain SM, Hunter K and Zujewski JA: Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer. Breast Cancer Res Treat. 119:685–699. 2010. View Article : Google Scholar

Griesinger AM, Birks DK, Donson AM, Amani V, Hoffman LM, Waziri A, Wang M, Handler MH and Foreman NK: Characterization of distinct immunophenotypes across pediatric brain tumor types. J Immunol. 191:4880–4888. 2013. View Article : Google Scholar : PubMed/NCBI

Qi H, Wang P, Sun H, Li X, Hao X, Tian W, Yu L, Tang J, Dong J and Wang H: ADAMDEC1 accelerates GBM progression via activation of the MMP2-related pathway. Front Oncol. 12:9450252022. View Article : Google Scholar : PubMed/NCBI

Guda MR, Velpula KK, Asuthkar S, Cain CP and Tsung AJ: Targeting RGS4 ablates glioblastoma proliferation. Int J Mol Sci. 21:33002020. View Article : Google Scholar : PubMed/NCBI

Yasmin IA, Mohana Sundaram S, Banerjee A, Varier L, Dharmarajan A and Warrier S: Netrin-like domain of sFRP4, a wnt antagonist inhibits stemness, metastatic and invasive properties by specifically blocking MMP-2 in cancer stem cells from human glioma cell line U87MG. Exp Cell Res. 409:1129122021. View Article : Google Scholar : PubMed/NCBI

Georgescu MM, Islam MZ, Li Y, Traylor J and Nanda A: Novel targetable FGFR2 and FGFR3 alterations in glioblastoma associate with aggressive phenotype and distinct gene expression programs. Acta Neuropathol Commun. 9:692021. View Article : Google Scholar : PubMed/NCBI

Sanders S, Herpai DM, Rodriguez A, Huang Y, Chou J, Hsu FC, Seals D, Mott R, Miller LD and Debinski W: The presence and potential role of ALDH1A2 in the glioblastoma microenvironment. Cells. 10:24852021. View Article : Google Scholar : PubMed/NCBI

Kreße N, Schröder H, Stein KP, Wilkens L, Mawrin C, Sandalcioglu IE and Dumitru CA: PLOD2 is a prognostic marker in glioblastoma that modulates the immune microenvironment and tumor progression. Int J Mol Sci. 23:60372022. View Article : Google Scholar

Ivanova EL, Costa B, Eisemann T, Lohr S, Boskovic P, Eichwald V, Meckler J, Jugold M, Orian-Rousseau V, Peterziel H and Angel P: CD44 expressed by myeloid cells promotes glioma invasion. Front Oncol. 12:9697872022. View Article : Google Scholar : PubMed/NCBI

Wang P, Hao X, Li X, Yan Y, Tian W, Xiao L, Wang Z and Dong J: Curcumin inhibits adverse psychological stress-induced proliferation and invasion of glioma cells via down-regulating the ERK/MAPK pathway. J Cell Mol Med. 25:7190–7203. 2021. View Article : Google Scholar : PubMed/NCBI

Yang CL, Chik SC, Lau AS and Chan GC: Coriolus versicolor and its bioactive molecule are potential immunomodulators against cancer cell metastasis via inactivation of MAPK pathway. J Ethnopharmacol. 301:1157902023. View Article : Google Scholar

Gallardo-Pérez JC, Trejo-Solís MC, Robledo-Cadena DX, López-Marure R, Agredano-Moreno LT, Jimenez-García LF and Sánchez-Lozada LG: Erythrose inhibits the progression to invasiveness and reverts drug resistance of cancer stem cells of glioblastoma. Med Oncol. 40:1042023. View Article : Google Scholar : PubMed/NCBI

Luo Z, Liu L, Li X, Chen W and Lu Z: Tat-NTS suppresses the proliferation, migration and invasion of glioblastoma cells by inhibiting annexin-A1 nuclear translocation. Cell Mol Neurobiol. 42:2715–2725. 2022. View Article : Google Scholar

Zhou Y, Liu H, Zheng W, Chen Q, Hu S, Pan Y, Bai Y, Zhang J and Shao C: MMP14 contributes to HDAC inhibition-induced radiosensitization of glioblastoma. Int J Mol Sci. 22:104032021. View Article : Google Scholar : PubMed/NCBI

Dosta P, Dion MZ, Prado M, Hurtado P, Riojas-Javelly CJ, Cryer AM, Soria Y, Andrews Interiano N, Muñoz-Taboada G and Artzi N: Matrix metalloproteinase- and pH-sensitive nanoparticle system enhances drug retention and penetration in glioblastoma. ACS Nano. 18:14145–14160. 2024. View Article : Google Scholar : PubMed/NCBI

Li Y, Wang D, Zhang Z, Wang Y, Zhang Z, Liang Z, Liu F and Chen L: Photodynamic therapy enhances the cytotoxicity of temozolomide against glioblastoma via reprogramming anaerobic glycolysis. Photodiagn Photodyn Ther. 42:1033422023. View Article : Google Scholar

Rezaei T, Hejazi M, Mansoori B, Mohammadi A, Amini M, Mosafer J, Rezaei S, Mokhtarzadeh A and Baradaran B: microRNA-181a mediates the chemo-sensitivity of glioblastoma to carmustine and regulates cell proliferation, migration, and apoptosis. Eur J Pharmacol. 888:1734832020. View Article : Google Scholar : PubMed/NCBI

Chen CJ, Shang HS, Huang YL, Tien N, Chen YL, Hsu SY, Wu RS, Tang CL, Lien JC, Lee MH, et al: Bisdemethoxycurcumin suppresses human brain glioblastoma multiforme GBM 8401 cell migration and invasion via affecting NF-κB and MMP-2 and MMP-9 signaling pathway in vitro. Environ Toxicol. 37:2388–2397. 2022. View Article : Google Scholar : PubMed/NCBI

Jalili-Nik M, Afshari AR, Sabri H, Bibak B, Mollazadeh H and Sahebkar A: Zerumbone, a ginger sesquiterpene, inhibits migration, invasion, and metastatic behavior of human malignant glioblastoma multiforme in vitro. BioFactors. 47:729–739. 2021. View Article : Google Scholar : PubMed/NCBI

Cheng B, Hong X, Wang L, Cao Y, Qin D, Zhou H and Gao D: Curzerene suppresses progression of human glioblastoma through inhibition of glutathione S-transferase A4. CNS Neurosci Ther. 28:690–702. 2022. View Article : Google Scholar : PubMed/NCBI

Alkahtani S, Sal-Johani N, Alarifi S and Afzal M: Cytotoxicity mechanisms of blue-light-activated curcumin in T98G cell line: Inducing apoptosis through ROS-dependent downregulation of MMP pathways. Int J Mol Sci. 24:38422023. View Article : Google Scholar : PubMed/NCBI

Han M, An J, Li S, Fan H, Wang L, Du Q, Du J, Yang Y, Song Y and Peng F: Isocucurbitacin B inhibits glioma growth through PI3K/AKT pathways and increases glioma sensitivity to TMZ by inhibiting hsa-mir-1286a. Cancer Drug Resist. 7:162024.PubMed/NCBI

Yang JF, Chen TM, Chang HH, Tsai YL, Tsai WC, Huang WY, Lo CH, Lin CS, Shen PC and Chen Y: Guggulsterone inhibits migration and invasion through proteasomal and lysosomal degradation in human glioblastoma cells. Eur J Pharmacol. 938:1754112023. View Article : Google Scholar

Wang X, Zou S, Ren T, Zhao LJ, Yu LF, Li XY, Yan X and Zhang LJ: Alantolactone suppresses the metastatic phenotype and induces the apoptosis of glioblastoma cells by targeting LIMK kinase activity and activating the cofilin/G-actin signaling cascade. Int J Mol Med. 47:682021. View Article : Google Scholar :

Dos Santos JS, Suzan AJ, Bonafé GA, Fernandes AMAP, Longato GB, Antônio MA, Carvalho PO and Ortega MM: Kaempferol and biomodified kaempferol from sophora japonica extract as potential sources of anti-cancer polyphenolics against high grade glioma cell lines. Int J Mol Sci. 24:107162023. View Article : Google Scholar : PubMed/NCBI

Khathayer F and Ray SK: Diosgenin as a novel alternative therapy for inhibition of growth, invasion, and angiogenesis abilities of different glioblastoma cell lines. Neurochem Res. 45:2336–2351. 2020. View Article : Google Scholar : PubMed/NCBI

Liu HY, Ji YL, Du H, Chen SH, Wang DP and Lv QL: Bacoside a inhibits the growth of glioma by promoting apoptosis and autophagy in U251 and U87 cells. Naunyn Schmiedebergs Arch Pharmacol. 397:2105–2120. 2024. View Article : Google Scholar

Yang HL, Chang YH, Pandey S, Bhat AA, Vadivalagan C, Lin KY and Hseu YC: Antrodia camphorataand coenzyme Q0, a novel quinone derivative of antrodia camphorata, impede HIF-1α and epithelial-mesenchymal transition/metastasis in human glioblastoma cells. Environ Toxicol. 38:1548–1564. 2023. View Article : Google Scholar : PubMed/NCBI

Frontiñán-Rubio J, Llanos-González E, García-Carpintero S, Peinado JR, Ballesteros-Yáñez I, Rayo MV, de la Fuente J, Pérez-García VM, Perez-Romasanta LA, Malumbres M, et al: CoQ10 reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation. Cell Oncol (Dordr). 46:65–77. 2023. View Article : Google Scholar

Małek A, Strzemski M, Kapka-Skrzypczak L and Kurzepa J: Anticancer activity of melittin-containing bee venom fraction against glioblastoma cells in vitro. Int J Mol Sci. 26:23762025. View Article : Google Scholar :

Eidizade F, Soukhtanloo M, Zhiani R, Mehrzad J and Mirzavi F: Inhibition of glioblastoma proliferation, invasion, and migration by urolithin B through inducing G0/G1 arrest and targeting MMP-2/-9 expression and activity. BioFactors. 49:379–389. 2023. View Article : Google Scholar

Doğanlar O, Doğanlar ZB, Delen E and Doğan A: The role of melatonin in angio-miR-associated inhibition of tumorigenesis and invasion in human glioblastoma tumour spheroids. Tissue Cell. 73:1016172021. View Article : Google Scholar

Liu DN, Liu M, Zhang SS, Shang YF, Song FH, Zhang HW, Du GH and Wang YH: Chrysomycin a inhibits the proliferation, migration and invasion of U251 and U87-MG glioblastoma cells to exert its anti-cancer effects. Molecules. 27:61482022. View Article : Google Scholar : PubMed/NCBI

Lin YH, Chen TM, Lai CR, Tsai YL, Tsai WC and Chen Y: GW4064 inhibits migration and invasion in human glioblastoma multiforme through the downregulation of PKCα. Eur J Pharmacol. 991:1773292025. View Article : Google Scholar

Wen ZH, Chang L, Yang SN, Yu CL, Tung FY, Kuo HM, Lu IC, Wu CY, Shih PC, Chen WF and Chen NF: The anti-angiogenic and anti-vasculogenic mimicry effects of GN25 in endothelial and glioma cells. Biochim Biophys Acta Mol Cell Res. 1871:1197992024. View Article : Google Scholar : PubMed/NCBI

Shan W, Zuo K and Zuo Z: Hypoglycemic agents increase regulatory factor X1 to inhibit cancer cell behaviour in human glioblastoma cells. J Cell Mol Med. 28:e702602024. View Article : Google Scholar : PubMed/NCBI

Benn KW, Yuan PH, Chong HK, Stylii SS, Luwor RB and French CR: hERG channel agonist NS1643 strongly inhibits invasive astrocytoma cell line SMA-560. PLoS One. 19:e03094382024. View Article : Google Scholar : PubMed/NCBI

Zhao H, Xing F, Yuan J, Li Z and Zhang W: Sevoflurane inhibits migration and invasion of glioma cells via regulating miR-34a-5p/MMP-2 axis. Life Sci. 256:1178972020. View Article : Google Scholar : PubMed/NCBI

Kang X, Li H and Zhang Z: Sevoflurane blocks glioma malignant development by upregulating circRELN through circRELN-mediated miR-1290/RORA axis. BMC Anesthesiol. 21:2132021. View Article : Google Scholar : PubMed/NCBI

Zhan X, Lei C and Yang L: Sevoflurane inhibits cell proliferation and migration of glioma by targeting the miR-27b/VEGF axis. Mol Med Rep. 23:4082021. View Article : Google Scholar :

Zhang L, Chen H, Tian C and Zheng D: Propofol represses cell growth and metastasis by modulating the circular RNA non-SMC condensin I complex subunit G/MicroRNA-200a-3p/RAB5A axis in glioma. World Neurosurg. 153:e46–e58. 2021. View Article : Google Scholar : PubMed/NCBI

Wang J, Zhang J, Zhang Q, Zhang W, Zhang Q, Jin G and Liu F: TS-2021, a third-generation oncolytic adenovirus that carried Ki67 promoter, TGF-β2 5'UTR, and IL−15 against experimental glioblastoma. J Med Virol. 96:e293352024. View Article : Google Scholar

Fan X, Li J, Long L, Shi T, Liu D, Tan W, Zhang H, Wu X, Lei X and Wang Z: Design, synthesis and biological evaluation of N-anthraniloyl tryptamine derivatives as pleiotropic molecules for the therapy of malignant glioma. Eur J Med Chem. 222:1135642021. View Article : Google Scholar : PubMed/NCBI

Gabano E, Gariboldi MB, Caron G, Ermondi G, Marras E, Vallaro M and Ravera M: Application of the anthraquinone drug rhein as an axial ligand in bifunctional pt(iv) complexes to obtain antiproliferative agents against human glioblastoma cells. Dalton Trans. 51:6014–6026. 2022. View Article : Google Scholar : PubMed/NCBI

Kuang J, Rao ZY, Zheng DW, Kuang D, Huang QX, Pan T, Li H, Zeng X and Zhang XZ: Nanoparticles hitchhike on monocytes for glioblastoma treatment after low-dose radiotherapy. ACS Nano. 17:13333–13347. 2023. View Article : Google Scholar : PubMed/NCBI

Durand M, Chateau A, Jubréaux J, Devy J, Paquot H, Laurent G, Bazzi R, Roux S, Richet N, Reinhard-Ruch A, et al: Radiosensitization with gadolinium chelate-coated gold nanoparticles prevents aggressiveness and invasiveness in glioblastoma. Int J Nanomedicine. 18:243–261. 2023. View Article : Google Scholar : PubMed/NCBI

Horta M, Soares P, Sarmento B, Leite Pereira C and Lima RT: Nanostructured lipid carriers for enhanced batimastat delivery across the blood-brain barrier: An in vitro study for glioblastoma treatment. Drug Deliv Transl Res. 15:2794–2813. 2025. View Article : Google Scholar : PubMed/NCBI

Gupta R and Sharma D: (carboxymethyl-stevioside)-coated magnetic dots for enhanced magnetic hyperthermia and improved glioblastoma treatment. Colloids Surf, B. 205:1118702021. View Article : Google Scholar

Ke G, Hu P, Xiong H, Zhang J, Xu H, Xiao C, Liu Y, Cao M and Zheng Q: Enhancing temozolomide efficacy in GBM: The synergistic role of chuanxiong rhizoma essential oil. Phytomedicine. 140:1565752025. View Article : Google Scholar : PubMed/NCBI

Pibuel MA, Poodts D, Sias SA, Byrne A, Hajos SE, Franco PG and Lompardía SL: 4-methylumbelliferone enhances the effects of chemotherapy on both temozolomide-sensitive and resistant glioblastoma cells. Sci Rep. 13:93562023. View Article : Google Scholar : PubMed/NCBI

Chen J, Zhuang YD, Zhang Q, Liu S, Zhuang BB, Wang CH and Liang RS: Exploring the mechanism of cordycepin combined with doxorubicin in treating glioblastoma based on network pharmacology and biological verification. PeerJ. 10:e129422022. View Article : Google Scholar : PubMed/NCBI

Wang J, Ren D, Sun Y, Xu C, Wang C, Cheng R, Wang L, Jia G, Ren J, Ma J, et al: Inhibition of PLK4 might enhance the anti-tumour effect of bortezomib on glioblastoma via PTEN/PI3K/AKT/mTOR signalling pathway. J Cell Mol Med. 24:3931–3947. 2020. View Article : Google Scholar : PubMed/NCBI

Qin JJ, Niu MD, Cha Z, Geng QH, Li YL, Ren CG, Molloy DP and Yu HR: TRAIL and celastrol combinational treatment suppresses proliferation, migration, and invasion of human glioblastoma cells via targeting wnt/β-catenin signaling pathway. Chin J Integr Med. 30:322–329. 2024. View Article : Google Scholar

Ebrahimi S, Mirzavi F, Hashemy SI, Khaleghi Ghadiri M, Stummer W and Gorji A: The in vitro anti-cancer synergy of neurokinin-1 receptor antagonist, aprepitant, and 5-aminolevulinic acid in glioblastoma. Biofactors. 49:900–911. 2023. View Article : Google Scholar : PubMed/NCBI

Torsvik A, Stieber D, Enger PØ, Golebiewska A, Molven A, Svendsen A, Westermark B, Niclou SP, Olsen TK, Chekenya Enger M and Bjerkvig R: U-251 revisited: Genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells. Cancer Med. 3:812–824. 2014. View Article : Google Scholar : PubMed/NCBI

Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015. Neuro Oncol. 20(suppl_4): iv1–iv86. 2018. View Article : Google Scholar : PubMed/NCBI

Gritsch S, Batchelor TT and Gonzalez Castro LN: Diagnostic, therapeutic, and prognostic implications of the 2021 world health organization classification of tumors of the central nervous system. Cancer. 128:47–58. 2022. View Article : Google Scholar

Satgunaseelan L, Sy J, Shivalingam B, Sim HW, Alexander KL and Buckland ME: Prognostic and predictive biomarkers in central nervous system tumours: The molecular state of play. Pathology. 56:158–169. 2024. View Article : Google Scholar : PubMed/NCBI

Groves MD, Puduvalli VK, Hess KR, Jaeckle KA, Peterson P, Yung WK and Levin VA: Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme. J Clin Oncol. 20:1383–1388. 2002. View Article : Google Scholar : PubMed/NCBI

Wolburg H, Wolburg-Buchholz K, Fallier-Becker P, Noell S and Mack AF: Structure and functions of aquaporin-4-based orthogonal arrays of particles. Int Rev Cell Mol Biol. 287:1–41. 2011. View Article : Google Scholar : PubMed/NCBI

Endicott JA and Ling V: The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem. 58:137–171. 1989. View Article : Google Scholar : PubMed/NCBI

Van Tellingen O, Yetkin-Arik B, De Gooijer MC, Wesseling P, Wurdinger T and De Vries HE: Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. Drug Resist Updat. 19:1–12. 2015. View Article : Google Scholar : PubMed/NCBI

Parrish KE, Sarkaria JN and Elmquist WF: Improving drug delivery to primary and metastatic brain tumors: Strategies to overcome the blood-brain barrier. Clin Pharmacol Ther. 97:336–346. 2015. View Article : Google Scholar : PubMed/NCBI

Oberoi RK, Parrish KE, Sio TT, Mittapalli RK, Elmquist WF and Sarkaria JN: Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma. Neuro Oncol. 18:27–36. 2016. View Article : Google Scholar

Wu D, Chen Q, Chen X, Han F, Chen Z and Wang Y: The blood-brain barrier: Structure, regulation and drug delivery. Signal Transduct Target Ther. 8:2172023. View Article : Google Scholar

Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, et al: MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell. 99:81–92. 1999. View Article : Google Scholar : PubMed/NCBI

Martignetti JA, Aqeel AA, Sewairi WA, Boumah CE, Kambouris M, Mayouf SA, Sheth KV, Eid WA, Dowling O, Harris J, et al: Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet. 28:261–265. 2001. View Article : Google Scholar : PubMed/NCBI

Barish ME, Aftabizadeh M, Hibbard J, Blanchard MS, Ostberg JR, Wagner JR, Manchanda M, Paul J, Stiller T, Aguilar B, et al: Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety. Cell Rep Med. 6:1023022025. View Article : Google Scholar : PubMed/NCBI

Thanh HD, Lee S, Nguyen TT, Huu TN, Ahn EJ, Cho SH, Kim MS, Moon KS and Jung C: Temozolomide promotes matrix metalloproteinase 9 expression through p38 MAPK and JNK pathways in glioblastoma cells. Sci Rep. 14:143412024. View Article : Google Scholar : PubMed/NCBI

Whitehead CA, Morokoff AP, Kaye AH, Drummond KJ, Mantamadiotis T and Stylli SS: Invadopodia associated thrombospondin-1 contributes to a post-therapy pro-invasive response in glioblastoma cells. Exp Cell Res. 431:1137432023. View Article : Google Scholar : PubMed/NCBI

Żwierełło W, Maruszewska A, Skórka-Majewicz M, Wszołek A and Gutowska I: Is fluoride blameless?-the influence of fluorine compounds on the invasiveness of the human glioma-like cell line U-87. Int J Mol Sci. 25:127732024. View Article : Google Scholar : PubMed/NCBI

Huang W, Li J, Geng X, Li S, Zou Y, Li Y, Jing C and Yu H: The reactive astrocytes after surgical brain injury potentiates the migration, invasion, and angiogenesis of C6 glioma. World Neurosurg. 168:e595–e606. 2022. View Article : Google Scholar : PubMed/NCBI

Ahmed MM, Hossain MM, Islam MR, Ali MS, Nafi AAN, Ahmed MF, Ahmed KM, Miah MS, Rahman MM, Niu M and Islam MK: Brain tumor detection and classification in MRI using hybrid ViT and GRU model with explainable AI in Southern Bangladesh. Sci Rep. 14:227972024. View Article : Google Scholar : PubMed/NCBI

Rastogi A, Brugnara G, Foltyn-Dumitru M, Mahmutoglu MA, Preetha CJ, Kobler E, Pflüger I, Schell M, Deike-Hofmann K, Kessler T, et al: Deep-learning-based reconstruction of undersampled MRI to reduce scan times: A multicentre, retrospective, cohort study. Lancet Oncol. 25:400–410. 2024. View Article : Google Scholar : PubMed/NCBI

Lu CH, Wei ST, Liu JJ, Chang YJ, Lin YF, Yu CS and Chang SL: Recognition of a novel gene signature for human glioblastoma. Int J Mol Sci. 23:41572022. View Article : Google Scholar : PubMed/NCBI

Shi J: Machine learning and bioinformatics approaches for classification and clinical detection of bevacizumab responsive glioblastoma subtypes based on miRNA expression. Sci Rep. 12:86852022. View Article : Google Scholar : PubMed/NCBI

Rivera CA, Bhatia S, Uppalapati V, Berke CN, Merenzon MA, Daggubati LC, Levy AS, Shah AH, Komotar RJ and Ivan ME: Leveraging machine learning for preoperative prediction of supramaximal ablation in laser interstitial thermal therapy for brain tumors. Neurosurg Focus. 57:E62024. View Article : Google Scholar : PubMed/NCBI

Kuenzi BM, Park J, Fong SH, Sanchez KS, Lee J, Kreisberg JF, Ma J and Ideker T: Predicting drug response and synergy using a deep learning model of human cancer cells. Cancer Cell. 38:672–684.e6. 2020. View Article : Google Scholar : PubMed/NCBI

Marques L, Costa B, Pereira M, Silva A, Santos J, Saldanha L, Silva I, Magalhães P, Schmidt S and Vale N: Advancing precision medicine: A review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare. Pharmaceutics. 16:3322024. View Article : Google Scholar : PubMed/NCBI

Seo S, Nah S, Lee K, Choi N and Kim HN: Triculture model of in vitro BBB and its application to study BBB-associated chemosensitivity and drug delivery in glioblastoma. Adv Funct Mater. 32:21068602022. View Article : Google Scholar

Tricinci O, De Pasquale D, Marino A, Battaglini M, Pucci C and Ciofani G: A 3D biohybrid real-scale model of the brain cancer microenvironment for advanced in vitro testing. Adv Mater Technol. 5:20005402020. View Article : Google Scholar : PubMed/NCBI

Zhu D, Trinh P, Li J, Grant GA and Yang F: Gradient hydrogels for screening stiffness effects on patient-derived glioblastoma xenograft cellfates in 3D. J Biomed Mater Res A. 109:1027–1035. 2021. View Article : Google Scholar

Wang C, Sinha S, Jiang X, Murphy L, Fitch S, Wilson C, Grant G and Yang F: Matrix stiffness modulates patient-derived glioblastoma cell fates in three-dimensional hydrogels. Tissue Eng Part A. 27:390–401. 2021. View Article : Google Scholar :